Garland Jason K

CFO

Garland Jason K has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jul 17, 2026.

On the most recent filing, Garland Jason K is listed as CFO at REPLIGEN CORP. Inside the rolling window, Garland Jason K reported no open-market purchases and 2 open-market sales totaling $186K in RGEN. The largest disclosed transaction in the window is a sale of 733 RGEN shares on Jun 25, 2026, worth $106K.

Companies traded

Other insiders at RGEN

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$186K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
RGENSale$80KJul 17SEC ↗
RGENSale$106KJun 26SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Garland Jason K made?

Garland Jason K has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.

Which companies does Garland Jason K trade?

Garland Jason K has filed SEC Form 4 disclosures for 1 company, including RGEN.

When was Garland Jason K's most recent SEC Form 4 filing?

Garland Jason K's most recent SEC Form 4 filing on Tracefour is dated Jul 17, 2026.

What is Garland Jason K's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Garland Jason K is listed as CFO.

What is Garland Jason K's total buy and sell value in the current window?

Inside the rolling retention window, Garland Jason K bought $0 and sold $186K based on SEC Form 4 filings.

What was Garland Jason K's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 733 RGEN shares on 2026-06-25, worth $106K, per SEC Form 4 filings.